Age at diagnosis (years) |
Mean (SD) |
7.9(4) |
6.9 (4.2) |
|
Median (IQR) |
7.8(4.5-11.2) |
6 (3, 10) |
Sex |
Male |
73(54%) |
91 (57%) |
|
Female |
63(46%) |
69 (43%) |
Distance to MTRH |
|
(n=136) |
(n=157) |
|
<100 Km |
54(40%) |
32 (20%) |
|
>100 Km |
82(60%) |
125 (80%) |
Duration of symptoms before admission at MTRH |
|
(N=132) |
(N=156) |
|
<1 month |
31(23%) |
57 (36%) |
|
1-3 months |
68(52%) |
72 (45%) |
|
> 3months |
33(25%) |
27 (17%) |
Health insurance (NHIF) status |
|
(n=136) |
(n=123) |
|
NHIF at the start of treatment |
71(52%) |
80 (65%) |
|
NHIF during treatment |
43(32% |
40 (33%) |
|
No NHIF |
22(16%) |
3 (2%) |
WBC count at diagnosis (x109 /L) (n=123) |
<50 |
|
81 (66%) |
|
≥50 |
|
42 (34%) |
ALL immunophenotypes (n=123) |
B-cell precursor |
|
33
(27%) |
|
T-cell |
|
8 (6%) |
|
Not determined |
|
82 (67%) |
CNS status (n=123) |
Negative |
|
94 (76%) |
|
Positive |
|
24 (20%) |
|
Not determined |
|
5 (4%) |